Alteration of somatostatin receptor 2 expression in canine mammary gland tumor

DOI Web Site Web Site PubMed 11 References Open Access
  • SAKAI Kosei
    Department of Veterinary Pathology, School of Veterinary Medicine, Kitasato University, Aomori 034–8628, Japan
  • YONEZAWA Tomohiro
    Laboratory of Veterinary Clinical Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113–8657, Japan
  • YAMAWAKI Hideyuki
    Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori 034–8628, Japan
  • OYAMADA Toshifumi
    Department of Veterinary Pathology, School of Veterinary Medicine, Kitasato University, Aomori 034–8628, Japan

Bibliographic Information

Other Title
  • Pathology : Alteration of somatostatin receptor 2 expression in canine mammary gland tumor

Search this article

Abstract

Somatostatin receptor 2 (SSTR2) is a negative regulator of cell proliferation in human breast cancer. Since there is little information about SSTR2 in canine mammary gland tumor (MGT), we clarified its distribution and expression level in normal mammary gland, benign MGT and malignant MGT. SSTR2 expression determined by immunohistochemical staining was observed in the cytoplasm of luminal epithelial cells. The intensity was negatively correlated with malignancy: normal tissues and some of the benign tumors had the highest levels, while the malignant tumors had little or no SSTR2 expression. As for the Western blotting, SSTR2 protein level in benign tumors was significantly lower than the normal mammary gland. On the other hand, SSTR2 protein levels in two of three malignant tumors were higher than the other groups. These results suggest that SSTR2 expression alters according to the malignancy of canine MGT.

Journal

References(11)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top